Should I buy Axalta (AXTA) stock or is it too late?

Axalta · Materials · price $37

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Baird — 62% of its targets hit on this sector (39 calls tested). It aims for $37 (+0.8 %), call made on July 30, 2026, maturing on July 30, 2027 (29 d ago).

The 2 reliable analysts $38+3.5 %

The 5 other firms $36-1.9 %

How to read it: the 2 reliable firms are not filtered by optimism — 2 aim above the price, 0 below, hence their $38 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Axalta

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
UBS	60 %	+34.9 %	5	$32 -13%
Deutsche Bank	71 %	+18.9 %	7	$42 +14%
Keybanc	74 %	+16.4 %	19	$45 +23%
BMO Capital	50 %	+14.3 %	6	$39 +6%
RBC Capital	50 %	+8.5 %	10	$36 -2%
JP Morgan	44 %	+8.0 %	9	$29 -21%
Citigroup	70 %	+7.2 %	10	$42 +14%
Mizuho	62 %	+5.2 %	13	$39 +6%

In short — Should you invest in Axalta? Is it too late, still worth it? Analysts are split (29% buy, median target $37, i.e. +1%), and the most reliable on AXTA targets even higher. But it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

The most reliable firm on AXTA, B of A Securities (100% hit rate, 4 scored calls), targets $41 (call made on October 14, 2025, maturing on October 14, 2026) (+12%) in its most recent call.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 7 ratings, 5 are neutral.
Limited upside: the median target is only +1% from the current price.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
No dividend: your return depends only on price appreciation.

The analyst consensus on AXTA

Median target $37 (+1%) · 7 ratings · Hold consensus

Strong Buy00%

Buy229%

Hold571%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Axalta now?

We won't decide for you. The facts: 29% of analysts rate it a buy, median target $37 (+1%), and B of A Securities (most reliable on AXTA, 100%) targets $41. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in Axalta?

The stated upside is small: the median target ($37) sits just +1% from the price ($37) (most reliable on AXTA: B of A Securities, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Axalta still worth investing in?

It depends on the gap between the price ($37) and its estimated value: analysts target $37 on median (+1%), with 29% buys (most reliable on AXTA: B of A Securities, 100%). Cross-check with their real reliability on AXTA and the cautions above. Information, not advice.

What's the main risk in buying AXTA?

The consensus is not unanimous: of 7 ratings, 5 are neutral.

→ Go deeper: the full Axalta profile (consensus, analyst reliability, price target, performance).